Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP)
In December 2006, after examining the available information collected on BZP (1-benzylpiperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint Report. Pursuant to the findings of this report, the Council of the EU formally requested a risk assessment of the substance, which was submitted to control measures and criminal penalties throughout the European Union in March 2008.
Download as PDF
Table of contents
- Information collection process
- Information requested by Article 5.2 of the Decision
- Information from the EMEA as requested by Article 5.3 of the Decision